17 December 2021 | News
COVAXIN️ has received EUL in Vietnam
The Republic of Vietnam will receive 2,00,000 doses of Bharat Biotech COVAXIN️. Suchitra Ella, Joint MD, Bharat Biotech revealed this at a function hosted by Vuong Dinh Hue, President of the National Assembly of the Socialist Republic of Vietnam in the presence of distinguished dignitaries in New Delhi.
The donation represents a gesture of goodwill to provide access to Bharat Biotech WHO approved, indigenously developed COVAXIN️ to fight the COVID-19 Pandemic across borders. COVAXIN️ has received EUL in Vietnam.
Bharat Biotech was invited by the Embassy of Vietnam for a one-on-one meeting with the President of the National Assembly, to discuss avenues of cooperation, supplies, and technology transfer possibilities.
Bharat Biotech has completed Phase-2 and Phase-3 trials of COVAXIN️ for children in the age group two to 18 years. The data has been submitted to the Central Drugs Standard Control Organisation (CDSCO) and the final approval is awaited. On approval, children will also have access to COVAXIN️.
In Vietnam, Bharat Biotech has been working with Duc Minh Medical JSC, towards the commercialisation of INDIRAB (Inactivated Rabies Vaccine). Duc Minh is Bharat Biotech's local partner in Vietnam.
Bharat Biotech has also supplied INDIRAB️ to the Republic Nation supporting their national rabies vaccine requirement.